Summary

Endometrial Ablation Market Growth & Trends

The global endometrial ablation market size is expected to reach USD 1.69 billion by 2030, expanding at a CAGR of 5.16% from 2023 to 2030, based on a new report by Grand View Research, Inc. This growth can be attributed to the growing prevalence of gynecological disorders and public awareness about endometrial ablation procedures. According to the Endocrine Society, PCOS affects between 7% and 10% of all women of reproductive age and is the foremost cause of infertility, which will certainly contribute to the overall market growth. Furthermore, the increased emphasis on raising awareness of gynecological cancer and the increasing prevalence of adenomyosis in women, especially after the age of 50 years, will have a positive impact on endometrial ablation surgery worldwide.

As per the United Nations ESCAP, out of the total population, around 53.2% of the population aged 60 years and above were women, and around 61.2% of the population aged 80 years and more were women in 2020. Thus, the rise in the geriatric women population also contributes to the market growth. Despite these favorable growth environments, the potential complications connected with uterine ablation surgery, like uterine perforation, high fever, and shortness of breath, may slightly impede market dynamics. Moreover, it has become possible to destroy the endometrium in situ in a day-care procedure due to the availability of minimally invasive endometrial ablation procedures as an alternative to surgeries. This procedure is less risky and technically simple to perform.

According to the International Federation of Gynecology and Obstetrics (FIGO), Abnormal Uterine Bleeding (AUB) in the reproductive years has a significant global impact, with an incidence of around 3 to 30% among reproductive-aged women. Thereby expected to propel the growth of the overall market. The global market players are undertaking various initiatives, such as organizing social media campaigns and launching websites to raise awareness about women-associated diseases, such as the AUB. This strategy enables companies to increase their capabilities, improve their competencies, and expand their product portfolios. For instance, in August 2022, Minerva Surgical, Inc. launched a “Time to Talk” social media campaign and local event series. This initiative will help raise awareness about AUB worldwide. This initiative will increase the consumer base for endometrial ablation devices, driving revenue generation.

Endometrial Ablation Market Report Highlights

• In 2022, the radiofrequency ablation (RFA) product segment dominated the market owing to the increased demand for RFA devices for removal of endometrial layers

• In 2022, the clinics segment dominated the market owing to the increased preference for clinics over hospitals to perform endometrial ablation procedures

• North America held the largest share in 2022 owing to the rising cases of gynecological disorders, improvement in healthcare infrastructure, and a strong foundation of top industry players to deliver cutting-edge endometrial ablation devices

• Market players adopt various strategies to increase the reach of their products in the market and improve availability in diverse geographic areas

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Endometrial Ablation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising number of uterine problems
3.2.1.2. Increasing preference towards minimally invasive surgical procedures
3.2.2. Market restraint analysis
3.2.2.1. Rising treatment costs
3.2.2.2. Presence of alternative treatment options
3.3. Endometrial Ablation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Endometrial Ablation Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2018 & 2030
4.2. Segment Dashboard
4.3. Global Endometrial Ablation Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.4.1. Cryoablation
4.4.1.1. Cryoablation market estimates and forecast 2018 to 2030 (USD Million)
4.4.2. Radiofrequency Ablation
4.4.2.1. Radiofrequency ablation market estimates and forecast 2018 to 2030 (USD Million)
4.4.3. Hydrothermal Ablation
4.4.3.1. Hydrothermal ablation market estimates and forecast 2018 to 2030 (USD Million)
4.4.4. Thermal Balloon
4.4.4.1. Thermal balloon market estimates and forecast 2018 to 2030 (USD Million)
4.4.5. Microwave Energy
4.4.5.1. Microwave energy market estimates and forecast 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Endometrial Ablation Market: End-use Estimates & Trend Analysis
5.1. End-use Market Share, 2018 & 2030
5.2. Segment Dashboard
5.3. Global Endometrial Ablation Market by End-use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.4.1. Hospitals
5.4.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.4.2. Clinics
5.4.2.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
5.4.3. Ambulatory Surgical Centers
5.4.3.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Endometrial Ablation Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2018 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory framework
6.5.1.4. Reimbursement scenario
6.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory framework
6.5.2.4. Reimbursement scenario
6.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory framework
6.6.1.4. Reimbursement scenario
6.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory framework
6.6.4.4. Reimbursement scenario
6.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory framework
6.6.5.4. Reimbursement scenario
6.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory framework
6.6.8.4. Reimbursement scenario
6.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Competitive Scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Competitive Scenario
6.9.4.3. Regulatory framework
6.9.4.4. Reimbursement scenario
6.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Medtronic.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. The Cooper Companies, Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Boston Scientific Corporation
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Johnson & Johnson Service Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Olympus Corporation
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Richard Wolf GmbH.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. AngioDynamics.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Hologic, Inc.
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Minerva Surgical, Inc.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives